Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes

Journal Title: 
Annals of internal medicine
Primary Author: 
Angelucci E
Author(s): 
Angelucci E, Greenberg P, Izquierdo M, Garcia-Manero G
Original Publication Date: 
Tuesday, October 6, 2020
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/33017548/
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.